Everlywell IPO
Everlywell is a direct-to-consumer health testing company that offers at-home lab tests for various health conditions and wellness metrics. The company provides convenient testing options for consumers who want to monitor their health without visiting traditional medical facilities. Investors may be interested in Everlywell's position in the growing telehealth and consumer health testing market.
Key Facts
| Industry | Digital Health |
| Founded | 2015 |
| Headquarters | Austin, TX |
| Employees | ~500 |
| Website | everlywell.com |
| Funding | Series D at $2.9B valuation. Total raised: $350M |
About Everlywell
Everlywell is a direct-to-consumer health testing company that allows individuals to collect samples at home and receive lab results digitally. The company offers over 30 different tests covering areas such as food sensitivities, hormone levels, sexually transmitted infections, and general wellness markers. Everlywell partners with CLIA-certified laboratories to process samples and provides physician review of results in most states.
The company gained significant attention during the COVID-19 pandemic by offering at-home testing solutions when traditional testing was limited. Everlywell has expanded beyond individual consumers to serve employers and healthcare providers with workplace testing programs and telehealth services. The platform represents a shift toward consumer-driven healthcare, allowing people to access diagnostic testing without traditional healthcare gatekeepers, though the company has faced some regulatory scrutiny over direct-to-consumer testing practices.
IPO Status
Everlywell has not announced plans for an initial public offering, despite being a well-known player in the direct-to-consumer health testing space. The company has raised significant venture capital funding, including a Series C round that reportedly valued the company at over $2 billion in 2021. The company experienced significant growth during the COVID-19 pandemic as demand for at-home testing surged. However, like many telehealth companies, Everlywell would need to demonstrate sustainable growth beyond pandemic-driven demand to attract IPO investors. No confirmed timeline for going public has been announced.
Competitors
Frequently Asked Questions
Does Everlywell have a stock?
No, Everlywell has not had an IPO and remains a private company. Despite being a prominent player in the at-home health testing market, the company has not announced IPO plans.
When is the Everlywell IPO date?
Everlywell has not announced an IPO date or timeline. While the company has achieved significant growth and valuation in private markets, no public offering has been confirmed.
How can I buy Everlywell stock?
Everlywell stock is not currently available for public purchase as it remains privately held. If the company goes public in the future, shares would be available through brokers and trading platforms.
Stay Updated on the Everlywell IPO
Get real-time alerts when Everlywell files for an IPO, prices shares, or begins trading.
Get IPO Alerts